Clinical Trial Update: D4T or Abacavir Plus Vitamin Enhancement in HIV-Infected Patients (DAVE) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for HIV-infected patients evaluating D4T (stavudine) or abacavir with vitamin enhancement; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Lactic Acidosis

Drugs mentioned

• Vitamin supplementation (Vitamin supplementation)
• Ziagen (Abacavir)
• stavudine (stavudine)

Snippet

Sponsor: University of British Columbia | Conditions: Acidosis, Lactic | Phase 2, Phase 3 | Status: COMPLETED